SLC27A2 Antikörper (AA 283-620) (FITC)
-
- Target Alle SLC27A2 Antikörper anzeigen
- SLC27A2 (Solute Carrier Family 27 (Fatty Acid Transporter), Member 2 (SLC27A2))
-
Bindungsspezifität
- AA 283-620
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser SLC27A2 Antikörper ist konjugiert mit FITC
-
Applikation
- ELISA, Western Blotting (WB)
- Kreuzreaktivität
- Human
- Aufreinigung
- >95%, Protein G purified
- Immunogen
- Recombinant Human Very long-chain acyl-CoA synthetase protein (283-620AA)
- Isotyp
- IgG
- Top Product
- Discover our top product SLC27A2 Primärantikörper
-
-
- Applikationshinweise
- Optimal working concentration should be determinde by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 - Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClinTM: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Handhabung
- Avoid repeated freeze.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- SLC27A2 (Solute Carrier Family 27 (Fatty Acid Transporter), Member 2 (SLC27A2))
- Andere Bezeichnung
- SLC27A2 (SLC27A2 Produkte)
- Synonyme
- vlcs antikoerper, fatp2 antikoerper, vlacs antikoerper, acsvl1 antikoerper, facvl1 antikoerper, im:7139614 antikoerper, slc27a2 antikoerper, wu:fb99g05 antikoerper, zgc:112376 antikoerper, ACSVL1 antikoerper, FACVL1 antikoerper, HsT17226 antikoerper, hFACVL1 antikoerper, FATP2 antikoerper, VLCS antikoerper, Vlac antikoerper, Vlacs antikoerper, VLACS antikoerper, solute carrier family 27 (fatty acid transporter), member 2 L homeolog antikoerper, solute carrier family 27 member 2 antikoerper, solute carrier family 27 (fatty acid transporter), member 2a antikoerper, solute carrier family 27 (fatty acid transporter), member 2 antikoerper, slc27a2.L antikoerper, SLC27A2 antikoerper, slc27a2a antikoerper, slc27a2 antikoerper, Slc27a2 antikoerper
- Hintergrund
-
Background: Acyl-CoA synthetase probably involved in bile acid metabolism. Proposed to activate C27 precursors of bile acids to their CoA thioesters derivatives before side chain cleavage via peroxisomal beta-oxidation occurs. In vitro, activates 3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-cholestanate (THCA), the C27 precursor of cholic acid deriving from the de novo synthesis from cholesterol. Does not utilize C24 bile acids as substrates. In vitro, also activates long- and branched-chain fatty acids and may have additional roles in fatty acid metabolism. May be involved in translocation of long-chain fatty acids (LFCA) across membranes (By similarity).
Aliases: ACSVL1 antibody, FACVL1 antibody, FATP 2 antibody, FATP-2 antibody, FATP2 antibody, Fatty acid coenzyme A ligase, very long chain 1 antibody, Fatty acid transport protein 2 antibody, Fatty-acid-coenzyme A ligase antibody, hFACVL1 antibody, HsT17226 antibody, Long chain fatty acid CoA ligase antibody, Long-chain-fatty-acid--CoA ligase antibody, S27A2_HUMAN antibody, Slc27a2 antibody, Solute carrier family 27 (fatty acid transporter), member 2 antibody, Solute carrier family 27 member 2 antibody, THCA CoA ligase antibody, THCA-CoA ligase antibody, Very long chain acyl CoA synthetase antibody, Very long chain fatty acid CoA ligase antibody, Very long chain fatty acid coenzyme A ligase 1 antibody, very long-chain 1 antibody, Very long-chain acyl-CoA synthetase antibody, Very long-chain-fatty-acid-CoA ligase antibody, VLACS antibody, VLCS antibody
- UniProt
- Q9Y2P5
- Pathways
- Monocarboxylic Acid Catabolic Process, SARS-CoV-2 Protein Interaktom
-